BONA
1.12.2021 08:32:10 CET | Business Wire | Press release
Bona® , a global, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium floors, and Scania, one of the world's leading providers of transport solutions, hosted an event yesterday to welcome Bona’s first electric truck to its facility in Limburg, Germany. The Scania innovated truck is from the Scania P series and will offer an emission-free transport system for Bona’s operations in Limburg and the surrounding area. It is the first of its kind to be operated in Germany.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005952/en/
"Bona is committed to incorporating and pursuing sustainable products, systems, and practices throughout the company and the new Scania electric truck is an important milestone in our journey to a greener future,” said Dr. Thomas Brokamp, Managing Director, Bona Germany. “Scania advised us well on the choice of our electric vehicle and gave us a good introduction to this new technology. The Scania electric truck is perfectly tailored to our needs and areas of operation.” The battery-electric truck will act as a city shuttle, making multiple trips a day to transport finished products from the production plant in the south of the city to the distribution center in the north, just under six kilometers away. Approximately 21 euro pallets can be accommodated in the loading area on each tour.
A POWERFUL DRIVE SYSTEM AND COMFORTABLE RIDE
The new model in the Scania P series, called the Scania 25 P, was specially designed for inner-city use and is characterized by comfortable access to the cab and excellent traffic visibility. The number in the model designation indicates the power that the truck travels, up to 230 kW (312 hp) rated engine power, which is enough power to move the three-axle truck's permissible weight of 26 tons with ease.
"The electric powertrain shines, especially at low engine speeds and in starting situations, with significantly better acceleration and more tractive power compared to a diesel truck," said Christian Hottgenroth, Director of Truck Sales, Scania Germany Austria. “In practice, drivers can therefore look forward to rapid acceleration and short response times from the drive.”
The Scania 25 P stores the energy for propulsion in five lithium-ion batteries, each with a capacity of 33 kW/h. "The electric range depends primarily on the factors of driving style, load, as well as topography," Hottgenroth explained further. Under optimal conditions, the drive batteries with the total capacity of 165 kW/h are designed for a range of up to 110 kilometers, while 70 to 90 kilometers can be expected in real driving conditions. For Bona’s use in the city of Limburg, which will average approximately 50 kilometers per day, the power is completely sufficient for the planned operating profile.
POWERED WITH SUSTAINABLE ENERGY
Because Bona’s Limburg facility is equipped with solar panels, the new Scania truck will be fueled by green electricity generated by a powerful photovoltaic system on the roof of the large hall. The fully electric truck is charged with direct current and is equipped with a charging capacity of 130 kW, which allows the batteries to be fully charged in about an hour at 20 percent capacity. If more range is required, a stop of half an hour at the charging station is enough to charge energy for another 50 or 60 kilometers.
“Moving to an emission-free vehicle is an important part of our broader sustainability journey and part of our commitment to be a good citizen. Due to high traffic the city of Limburg has a problem with excessively high nitrogen dioxide levels. The main source are diesel vehicles, and it is now extremely likely a ban for these vehicles is coming 1st of April 2022 for Limburg. With our emission-free truck we can make a valuable contribution in Limburg to lower nitrogen dioxide levels and to global decarbonization," said Dr. Brokamp. The fact that the electric truck from Scania also runs locally with zero emissions and is virtually noise-free due to its low-noise drive are also benefits of the all-electric truck.
Bona is in the process of finalizing the electric charging station, which is slated for completion by early 2022.
ABOUT BONA
Bona is a family-owned, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium floors. Founded in 1919, Bona was the first in the industry to offer a full system of waterborne hardwood floor finishing and floor care products. Today, Bona offers products for most premium floor surfaces including wood, tile, vinyl, resilient, rubber, and laminate. Bona’s turnover is 3.1bn SEK (EUR 307 million) 2020. The head office is in Malmö, Sweden, and the company is represented globally by its 17 subsidiaries, 70 distributors, 600 employees, and 5 factories. For more, visit www.bona.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130005952/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom